Sulfotransferases and acetyltransferases in mutagenicity testing: Technical aspects

被引:26
|
作者
Glatt, H [1 ]
Meinl, W [1 ]
机构
[1] German Inst Human Nutr, Dept Toxicol, Potsdam, Germany
关键词
D O I
10.1016/S0076-6879(05)00013-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Sulfotransferases (SULTs) and N-acetyltransferases (NATs) mediate the terminal activation step of various mutagens and carcinogens. Target cells of standard in vitro mutagenicity tests do not express any endogenous SULTs. NATs are expressed in some cells, but may not reflect the substrate specificity of human NATs. External activating systems usually lack the cofactors for these enzymes. Upon addition of the cofactor, the ultimate mutagen may be formed, but especially sulfo conjugates-anions-may not reliably penetrate into the target cells. This chapter presents methods used to incorporate these enzyme systems into in vitro mutagenicity test systems and to identify the critical human forms. The method of choice is direct expression of the enzymes in target cells. We present procedures on how this can be reached in bacteria and in mammalian cell lines in culture. Furthermore, genetically manipulated mouse models are a very promising perspective for answering open questions.
引用
收藏
页码:230 / 249
页数:20
相关论文
共 50 条
  • [1] LEGISLATIVE AND TECHNICAL ASPECTS OF MUTAGENICITY TESTING
    MAYER, VW
    FLAMM, WG
    MUTATION RESEARCH, 1975, 29 (02): : 295 - 300
  • [2] Use of genetically manipulated Salmonella typhimurium strains to evaluate the role of sulfotransferases and acetyltransferases in nitrofen mutagenicity
    Glatt, H
    Meinl, W
    CARCINOGENESIS, 2004, 25 (05) : 779 - 786
  • [3] N-acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast
    Williams, JA
    Stone, EM
    Fakis, G
    Johnson, N
    Cordell, JA
    Meinl, W
    Glatt, H
    Sim, E
    Phillips, DH
    PHARMACOGENETICS, 2001, 11 (05): : 373 - 388
  • [4] Practical aspects of mutagenicity testing strategy: an industrial perspective
    Gollapudi, BB
    Krishna, G
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 455 (1-2) : 21 - 28
  • [5] Technical aspects of HLA antibody testing
    Gebel, Howard M.
    Liwski, Robert S.
    Bray, Robert A.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2013, 18 (04) : 455 - 462
  • [6] New aspects of technical testing of intravascular stents
    Sergienko, V. I.
    Martynov, A. K.
    Petryaikin, A. V.
    Koshurnikov, D. S.
    Fadeev, A. A.
    Nikolaev, D. A.
    Karmazanovskii, G. G.
    Osipova, N. Yu.
    Fedorov, V. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (03) : 482 - 485
  • [7] New aspects of technical testing of intravascular stents
    V. I. Sergienko
    A. K. Martynov
    A. V. Petryaikin
    D. S. Koshurnikov
    A. A. Fadeev
    D. A. Nikolaev
    G. G. Karmazanovskii
    N. Yu. Osipova
    V. D. Fedorov
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 482 - 485
  • [8] Improving the Technical Aspects of Software Testing in Enterprises
    Majchrzak, Tim A.
    INTERNATIONAL JOURNAL OF ADVANCED COMPUTER SCIENCE AND APPLICATIONS, 2010, 1 (04) : 1 - 10
  • [9] Enzymatic aspects of the phenol (aryl) sulfotransferases
    Duffel, MW
    Marshall, AD
    McPhie, P
    Sharma, V
    Jakoby, WB
    DRUG METABOLISM REVIEWS, 2001, 33 (3-4) : 369 - 395
  • [10] LIVER-MICROSOME-SYSTEM - CRITICAL ASPECTS FOR ROUTINE MUTAGENICITY TESTING
    BUSELMAIER, W
    HERBOLD, B
    ROHRBORN, G
    MUTATION RESEARCH, 1976, 38 (02): : 137 - 138